The diabetic patient between sustainability and effectiveness of new treatments-Reference-Cited by-同舟云学术

The diabetic patient between sustainability and effectiveness of new treatments

Published:2023-09-16 Issue:2 Volume:22 Page:1635-1643
ISSN:2251-6581
Container-title:Journal of Diabetes & Metabolic Disorders
language:en
Short-container-title:J Diabetes Metab Disord

Author:

Ferrara Francesco^ORCID,Zovi Andrea^ORCID,Langella Roberto,Nava Eduardo,Trama Ugo

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40200-023-01296-0.pdf

Reference33 articles.

1. Associazione Medici Diabetologi (AMD)-Italian Society of Diabetology (SID). Italian Standards for the Care of Diabetes Mellitus 2018, http://www.siditalia.it/clinica/standards-of-care-amd-sid. Accessed Oct 2022.

2. Guideline of the Italian Society of Diabetology (SID) and the Association of Medical Diabetologists (AMD). The treatment of type 2 diabetes mellitus. https://www.iss.it/snlg-copertina.

3. Tsapas A, Avgerinos I, Karagiannis T, et al. Comparative efficacy of glucoselowering drugs for type 2 diabetes. Ann Intern Med. 2020;173:278–86. https://doi.org/10.7326/M20-0864.

4. The International Hypoglycaemia Study Group. Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management. Lancet Diabetes Endocrinol. 2019;7(18):385–96. https://doi.org/10.1016/S2213.

5. Bilgin S, Kurtkulagi O, Atak Tel BM, Duman TT, Kahveci G, Khalid A, Aktas G. Does C-reactive protein to serum albumin ratio correlate with diabEtic nephropathy in patients with type 2 dIabetes MEllitus? The CARE TIME study. Prim Care Diabetes. 2021;15(6):1071–4. https://doi.org/10.1016/j.pcd.2021.08.015.